Cardia Bioplastics (ASX:CNN) Net Income From Continuing Operations : A$-7.32 Mil (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Cardia Bioplastics Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Cardia Bioplastics's net income from continuing operations for the six months ended in Dec. 2023 was A$-3.05 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was A$-7.32 Mil.

Cardia Bioplastics Net Income From Continuing Operations Historical Data

The historical data trend for Cardia Bioplastics's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardia Bioplastics Net Income From Continuing Operations Chart

Cardia Bioplastics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Net Income From Continuing Operations

Get a 7-Day Free Trial

-4.17

-1.19

2.59

-3.09

-6.75

Cardia Bioplastics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Income From Continuing Operations	Get a 7-Day Free Trial															-0.79	-2.30	-2.48	-4.27	-3.05

Cardia Bioplastics Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-7.32 Mil.

Cardia Bioplastics (ASX:CNN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Cardia Bioplastics Ltd (ASX:CNN) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

SES:Australia

Address

247 Ferntree Gully Road, Unit 1, Mount Waverley, Melbourne, VIC, AUS, VIC 3149

Website

https://www.secosgroup.com.au

SECOS Group Ltd is an Australian developer and manufacturer of sustainable packaging materials. . Business operating segment includes the manufacture and distribution of polyethylene films, renewable resource-based resins, and finished products. It supplies proprietary biodegradable resins, packaging products cast films to a customer base spread globally.SECOS Global Application Development Centre is in Australia. Product Development Centre and manufacturing plant for resins and finished products in China and resins plant in Malaysia. It also has manufacturing plants for cast films in Malaysia. It conducts sales via geographical regions that include Australia, Asia, America, Europe, and Africa. Asia generates maximum revenue for the company.

Cardia Bioplastics (ASX:CNN) Headlines

No Headlines